Welcome to IDDST

The Annual Congress of International Drug Discovery Science &Technology (IDDST) initiated since 2003, it has been successfully hosted in Shanghai (China), Beijing (China), Shenzhen (China), Nanjing (China), Haikou (China), Suzhou (China), Xi’an (China), Gyeonggi (South Korea), Osaka (Japan), Boston (USA), Kyoto (Japan), Tokyo (Japan) and Amsterdam (the Netherlands) has attracted more than 10,000 participants from over 50 countries and regions in the previous 19 years. This year, the 20th Annual Congress of International Drug Discovery Science & Technology-2024 (IDDST-2024) will be held during May 22-24, 2024 at Osaka, Japan.


● Learn Global Market Trends for Drug Discovery
● Organize up to 150+ Oral Presentations on the Latest Trend
● 200+ Attendees to Exchange Ideas and Build New Networks
● Bring together 20+ Exhibitors and Posters on New Development
● Opportunities to Visit the local Natural and Cultural Landscapes

Keynote Speakers
Dr. Matthias von Herrath,
Scientific Director of the Diabetes Research Institute, University of Miami School of Medicine; Vice President, Novo Nordisk, USA
Dr. Diane J. Burgess,
Distinguished Professor and Pfizer Distinguished Chair of Pharmaceutical Technology, University of Connecticut, USA
Dr. Jeff Song,
Vice President, Boehringer Ingelheim Pharmaceuticals, Inc, USA
Dr. Muneto Mogi,
Global Head, Global Discovery Chemistry, Novartis Institutes for BioMedical Research (NIBR), USA
Dr. Anne S.J. Lesage,
Chief Early Development Officer, Pharvaris GmbH, Switzerland
Dr. Antonio Cabal,
Sr. Director, Biology Based Modeling & Simulation, Eisai Inc., USA
Confirmed Renowned Speakers
Dr. Mats Larsson,
Professor, Department of Physics, Stockholm University, Sweden
Dr. Hans Keirstead,
Chief Executive Officer, AIVITA Biomedical, Inc., USA
Dr. Miles Cunningham,
Medical Director, Harvard Medical School, USA
Dr. Lloyd Friedman,
Professor, Yale University School of Medicine, USA
Dr. Farzin Farzaneh,
Chief Scientific Officer, Virocell Biologics Limited; Professor of Molecular Medicine, King’s College London, UK
Dr. Antonio Cabal,
Sr. Director, Biology Based Modeling & Simulation, Eisai Inc., USA
Dr. Richard B. Krueger,
Clinical Professor of Psychiatry, Columbia University, Department of Psychiatry, Vagelos College of Physicians & Surgeons, USA
Dr. George Udeani,
Professor and Head, Texas A&M University, USA
Dr. Marina Komaroff,
Senior Director, Biostatistics – Product Development, Noven Pharmaceuticals, Inc., USA
Dr. Yiqun Helen Li,
Head of IT Lilly Biotechnology Center, Eli Lilly and Company, USA
Dr. Bradly Keck,
Director, Pharmaron, USA
Dr. Andreas Seidl,
Chief Operating Officer, Leukocare AG, Germany
Dr. Kun Cheng,
Distinguished Professor, University of Missouri-Kansas City, USA
Dr. Raphael Serreau,
Professor, Paris Saclay by Pharmacologist, University of Orleans, France
Dr. Richard Denk,
Senior Consultant, Aseptic Processing & Containment, SKAN AG, Switzerland
Dr. Maria A. Miteva,
Research Director, INSERM, France
Dr. Shu Ye,
Professor, National University of Singapore, Singapore
Dr. Kiyoshi Nokihara,
Founder CEO & CSO, HiPep Laboratories, Japan
Dr. Miriam Kidron,
Chief Scientific Officer and Director, Oramed Pharmaceuticals, Israel
Dr. Frank Fan,
Head of Biology, Promega Corporation, USA
Dr. Yali Dou,
Professor of Medicine, University of Southern California, USA
Dr. Marcelo F. Vela,
Professor of Medicine, Mayo Clinic College of Medicine and Science, USA
Dr. Dulcie A Mulholland,
Professor, Department of Chemistry, University of Surrey, UK
Dr. Anne Lesage,
Chief Early Development Officer, Pharvaris B.V., Switzerland 
Dr. Jonathan D C Ross,
Professor, University Hospital Birmingham, Whittall Street Clinic, UK
Dr. Beka Solomon,
Professor, Tel-Aviv University, Israel
Dr. Gemma Budd,
Director of Business Development, Nanopharm, UK
Dr. Klaus Groschner,
Professor, Medical University of Graz, Austria
Dr. Elizabeth Kwong,
Co-Founder & Chief Development Officer, Kwong Eureka Solutions, Canada
Dr. Eduard Korkotian,
Professor, Weizmann Institute of Science, Israel
Dr. Michele Papa,
Professor, University of Campania, Italy
Dr. Nathalie Wauthoz,
Professor, Universite Libre de Bruxelles, Belgium
Dr. Michael Junger,
Head of Medical Device, Vaxxas Nanopatch, Australia
Dr. Yuhua Li,
Co-Founder, Sr. Vice President of R & D, Foresee Pharmaceuticals USA, Inc., USA
Dr. Valerie Gouon-Evans,
Associate Professor, Boston University School of Medicine, USA
Dr. Nir Debotton,
Director, Shenkar College of Engineering and Design, Israel
Exhibition and Poster

IDDST-2024 provides an ideal platform to showcase your novel technologies and products. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.

Why Reserve a Booth at IDDST-2024
• To Meet Face-to-Face with the International Movers and Shakers
• To Meet with Key Decision Marker
• To Explore Business Opportunities
• To Spotlight Advanced Technologies and Their Scientific and Commercial Applications
• To Take Advantage of the Conference's Captive Audience and Networking Opportunities within the Exhibition Hall


Exhibition Date:
Set-up date: May 21, 2024
Show dates: May 22-24, 2024
Place: Osaka, Japan

Concurrent Conference
IDDST Europe Conference
Hosting Organizations
World High Technology Society
Dalian Biteomics, Inc.
Support Organization
Journal Partner
Media Partner List

© 2003-2024 All rights reserved by BITeomics
Contact Us: Tel:0086-411-84799609,